Inventor · disambiguated record
Mircea Ivan
Also filed as: IVAN MIRCEA
7 granted patents·5 pending applications·82 citations·filing 2002–2020
85Inventor score
Top patents by PatentIndex Score
12 records- 0192US6855510B2Pharmaceuticals and methods for treating hypoxia and screening methods thereforDANA FARBER CANCER INST INC·Filed 2002·Granted Feb 15, 2005·41 cites·54 claims
- 0288US6849718B2Muteins of hypoxia inducible factor alpha and methods of use thereofDANA FARBER CANCER INST INC·Filed 2002·Granted Feb 1, 2005·31 cites·4 claims
- 0383US7985563B2HIFαprolyl hydroxylation assayDANA FARBER CANCER INST INC·Filed 2007·Granted Jul 26, 2011·4 cites·11 claims
- 0479US8809011B2HIFα hydroxylation assayKAELIN JR WILLIAM G·Filed 2011·Granted Aug 19, 2014·3 cites·6 claims
- 0576US2022291216A1Pharmaceuticals and methods for treating hypoxia and screening methods thereforDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0670US2020209239A1Pharmaceuticals and methods for treating hypoxia and screening methods thereforDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0767US9766240B2Method of identifying a compound for treating a hypoxic or ischemic related disorderDANA FARBER CANCER INST INC·Filed 2014·Granted Sep 19, 2017·0 cites·11 claims
- 0867US7361463B2Muteins of hypoxia inducible factor alpha and methods of use thereofDANA FARBER CANCER INST INC·Filed 2004·Granted Apr 22, 2008·3 cites·6 claims
- 0966US10365278B2Pharmaceuticals and methods for treating hypoxia and screening methods thereforDANA FARBER CANCER INST INC·Filed 2017·Granted Jul 30, 2019·0 cites·9 claims
- 1066US2010233735A1Pharmaceuticals and methods for treating hypoxia and screening methods thereforDANA FARBER CANCER INST INC·Filed 2008·Application pending·0 cites
- 1160US2005186650A1Pharmaceuticals and methods for treating hypoxia and screening methods thereforFiled 2004·Application pending·0 cites
- 1258US2004248233A1Pharmaceuticals and methods for treating hypoxia and screening methods thereforFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →